Skip to content

Trial Summary

An Australian, non-interventional registry to evaluate clinical outcomes and bevacizumab use in metastatic colorectal cancer from routine clinical practise.

Acronym:

TRACC

ACTRN/NCT /ethics:

N/A

Scientific title:

An Australian, non-interventional registry to evaluate clinical outcomes and bevacizumab use in metastatic colorectal cancer from routine clinical practise.

Sponsor / Cooperative group:

N/A

Trial & Patient Characteristics

Cancer TypeBowel and colon
Trial TypeEarly detection, diagnosis, prognosis
PhaseAll phases
Age Range18 years and older
SexBoth
Tumour Stream colorectal
Cancer StageMetastatic or Widespread
Anticipated Start DateN/A
Anticipated End DateN/A

Participating Hospitals

HospitalThe Queen Elizabeth Hospital
Clinical Trial CoordinatorPamela Cooper
Emailpamela.cooper@sa.gov.au
Phone08 8222 6140
Principal InvestigatorProfessor Tim Price
Recruitment StatusNot Yet Recruiting